Table 1.
Characteristics of the included studies (N=101).
| Characteristics | Colorectal cancer (n=83), n (%)a | Breast cancer (n=28), n (%) | Cervical cancer (n=19), n (%) | Total, (N=101), n (%) | ||
| Publication yearb | ||||||
|
|
2015 | 13 (15.7) | 4 (14.3) | 1 (5.3) | 15 (14.9) | |
|
|
2016 | 15 (18.1) | 6 (21.4) | 3 (15.8) | 18 (17.8) | |
|
|
2017 | 15 (18.1) | 5 (17.9) | 4 (21.1) | 21 (20.8) | |
|
|
2018 | 16 (19.3) | 2 (7.1) | 3 (15.8) | 18 (17.8) | |
|
|
2019 | 10 (12) | 5 (17.9) | 4 (21.1) | 13 (12.9) | |
|
|
2020 | 9 (10.8) | 5 (17.9) | 3 (15.8) | 11 (10.9) | |
|
|
2021 | 5 (6) | 1 (3.6) | 1 (5.3) | 5 (5) | |
| Publication type | ||||||
|
|
Peer-reviewed article | 78 (94) | 26 (92.9) | 16 (84.2) | 92 (91.1) | |
|
|
Report | 1 (1.2) | 2 (7.1) | 2 (10.5) | 4 (4) | |
|
|
Study protocol | 3 (3.6) | —c | — | 3 (3) | |
|
|
Other | 1 (1.2) | — | 1 (5.3) | 2 (2) | |
| Study design | ||||||
|
|
Nonexperimental | |||||
|
|
|
Descriptive | 15 (18.1) | 5 (17.9) | 4 (21.1) | 18 (17.8) |
|
|
|
Observational | 11 (13.3) | 9 (32.1) | 4 (21.1) | 15 (14.9) |
|
|
Experimental | |||||
|
|
|
RCTd | 24 (28.9) | 7 (25) | 5 (26.3) | 29 (28.7) |
|
|
Quasi-experimental | |||||
|
|
|
Pre-post study design | 17 (20.5) | 5 (17.9) | 2 (10.5) | 21 (20.8) |
|
|
|
Non-RCT | 3 (3.6) | 1 (3.6) | 3 (15.8) | 5 (5) |
|
|
|
Other quasi-experimental | 3 (3.6) | — | — | 3 (3.0) |
|
|
Other study designs | 10 (12) | 1 (3.6) | 1 (5.3) | 10 (9.9) | |
aPercentages were calculated based on column totals.
bPublication year represents studies published from January 2015 to June 2021.
cNot available.
dRCT: randomized controlled trial.